Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New findings reported from Princess Margaret Hospital describe advances in breast cancer
May 15th, 2008
" We conducted a multicenter, randomized trial to compare progression-free survival (PFS), overall survival (OS), and quality of life in women with metastatic breast cancer (MBC) receiving high-dose chemotherapy plus autologous stem-cell transplantation (ASCT; HDCT) compared with standard-dose therapy. Patient and Methods Between April 1997 and December 2000, 386 women with MBC and no prior chemotherapy for metastatic disease were registered," scientists in Toronto, Canada report. "After initial response to anthracycline- or taxane-based induction chemotherapy, 224 patients were randomly assigned: 112 to high-dose cyclophosphamide, mitoxantrone, and carboplatin...
Source: Women's Health Weekly (2008-05-15)
|
